289 related articles for article (PubMed ID: 15800202)
1. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
Stewart RS; Piccardo P; Ghetti B; Harris DA
J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
[TBL] [Abstract][Full Text] [Related]
2. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons.
Stewart RS; Harris DA
J Biol Chem; 2005 Apr; 280(16):15855-64. PubMed ID: 15671025
[TBL] [Abstract][Full Text] [Related]
3. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
4. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
6. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.
Chiesa R; Piccardo P; Ghetti B; Harris DA
Neuron; 1998 Dec; 21(6):1339-51. PubMed ID: 9883727
[TBL] [Abstract][Full Text] [Related]
7. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B
Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
9. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
[TBL] [Abstract][Full Text] [Related]
10. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
11. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.
Hetz C; Russelakis-Carneiro M; Wälchli S; Carboni S; Vial-Knecht E; Maundrell K; Castilla J; Soto C
J Neurosci; 2005 Mar; 25(11):2793-802. PubMed ID: 15772339
[TBL] [Abstract][Full Text] [Related]
12. A transgenic model of a familial prion disease.
Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
Arch Virol Suppl; 2000; (16):103-12. PubMed ID: 11214912
[TBL] [Abstract][Full Text] [Related]
13. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
14. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
15. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
16. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice.
Barmada S; Piccardo P; Yamaguchi K; Ghetti B; Harris DA
Neurobiol Dis; 2004 Aug; 16(3):527-37. PubMed ID: 15262264
[TBL] [Abstract][Full Text] [Related]
17. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.
Chiesa R; Piccardo P; Biasini E; Ghetti B; Harris DA
J Neurosci; 2008 Dec; 28(49):13258-67. PubMed ID: 19052217
[TBL] [Abstract][Full Text] [Related]
18. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
19. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of endoplasmic reticulum homeostasis facilitates prion replication.
Hetz C; Castilla J; Soto C
J Biol Chem; 2007 Apr; 282(17):12725-33. PubMed ID: 17329244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
